---
figid: PMC3293632__msb20122-f1
figtitle: Control of the EGFR pathway and cell cycle entry by miRNAs
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3293632
filename: msb20122-f1.jpg
figlink: /pmc/articles/PMC3293632/figure/f1/
number: F1
caption: Control of the EGFR pathway and cell cycle entry by miRNAs. The EGF receptor
  uses several downstream pathways to drive cell cycle progression. Similarly, miRNAs
  simultaneously modulate several of these downstream pathways to effect cell cycle
  progression. For instance, miR-124 co-downregulates AKT2, p38MAPK and STAT3 to inhibit
  the EGFR pathway leading to CDK downregulation, p27Kip1 upregulation and cell cycle
  inhibition. miR-147 also participates in AKT2 downregulation and simultaneously
  represses Cyclins (Cyc). These two examples show how a single miRNA can target several
  components of a signaling pathway and how two miRNAs can co-regulate the same target.
  These data also suggest the therapeutic value of miR-124 and miR-147 in treating
  EGFR-dependent tumors. Only a few representative molecules are shown for clarity.
papertitle: 'miRNAs versus oncogenes: the power of social networking.'
reftext: Marcos Malumbres. Mol Syst Biol. 2012;8:569-569.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9575347
figid_alias: PMC3293632__F1
figtype: Figure
redirect_from: /figures/PMC3293632__F1
ndex: 5e0e3de7-dee5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3293632__msb20122-f1.html
  '@type': Dataset
  description: Control of the EGFR pathway and cell cycle entry by miRNAs. The EGF
    receptor uses several downstream pathways to drive cell cycle progression. Similarly,
    miRNAs simultaneously modulate several of these downstream pathways to effect
    cell cycle progression. For instance, miR-124 co-downregulates AKT2, p38MAPK and
    STAT3 to inhibit the EGFR pathway leading to CDK downregulation, p27Kip1 upregulation
    and cell cycle inhibition. miR-147 also participates in AKT2 downregulation and
    simultaneously represses Cyclins (Cyc). These two examples show how a single miRNA
    can target several components of a signaling pathway and how two miRNAs can co-regulate
    the same target. These data also suggest the therapeutic value of miR-124 and
    miR-147 in treating EGFR-dependent tumors. Only a few representative molecules
    are shown for clarity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - mir-124
  - Erk7
  - rl
  - cyc
  - CycE
  - Cyt-c-d
  - Cyt-c-p
  - cype
  - Cdk4
  - Rbf
  - DCTN6-p27
  - dap
  - CG9588
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - STAT1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STAT3
  - AKT2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK3
  - MIR147A
  - CYCS
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - RB1
  - RBM45
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
